The Intellectual Property & Science business of Thomson Reuters has announced a collaboration with Susan G. Komen, the world's largest breast cancer organisation.
As part of this relationship, Susan G. Komen will have special access to Thomson Reuters Web of Science to contextualise and determine the efficacy of research it funds within the broader breast cancer research landscape. Thomson Reuters Web of Science is the premier scientific search and discovery platform and industry authority in science, social science, and arts & humanities citation indexes.
Since its inception in 1982, Susan G. Komen has provided more than $804 million in funding to more than 2,200 breast cancer research grants, making Komen the largest non-profit funder of breast cancer research outside of the U.S. government. This strategic relationship will provide Komen with the ability to track outcomes from their funded research projects and assess the contributions of their research portfolio toward the advancement of breast cancer research and patient care.
The organisation projects that 11 million women will die from breast cancer in the next 20 years, making the quantification of their research and its impact all the more urgent.
The Web of Science Core Collection offers authoritative, multidisciplinary content from more than 12,000 high impact research journals worldwide across more than 250 disciplines. Susan G. Komen joins more than 6,000 world leading scholarly institutions responsible for scientific research and policy making that utilize the Web of Science for strategic assessments.
